Literature DB >> 18061568

Snail1 is a transcriptional effector of FGFR3 signaling during chondrogenesis and achondroplasias.

Cristina A de Frutos1, Sonia Vega, Miguel Manzanares, Juana M Flores, Hector Huertas, M Luisa Martínez-Frías, M Angela Nieto.   

Abstract

Achondroplasias are the most common genetic forms of dwarfism in humans. They are associated with activating mutations in FGFR3, which signal through the Stat and MAPK pathways in a ligand-independent manner to impair chondrocyte proliferation and differentiation. Snail1 has been implicated in chondrocyte differentiation as it represses Collagen II and aggrecan transcription in vitro. Here we demonstrate that Snail1 overexpression in the developing bone leads to achondroplasia in mice. Snail1 acts downstream of FGFR3 signaling in chondrocytes, regulating both Stat and MAPK pathways. Moreover, FGFR3 requires Snail1 during bone development and disease as the inhibition of Snail1 abolishes its signaling even through achondroplastic- and thanatophoric-activating FGFR3 forms. Significantly, Snail1 is aberrantly upregulated in thanatophoric versus normal cartilages from stillborns. Thus, Snail activity may likely be considered a target for achondroplasia therapies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18061568     DOI: 10.1016/j.devcel.2007.09.016

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  42 in total

Review 1.  Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias.

Authors:  Silvie Foldynova-Trantirkova; William R Wilcox; Pavel Krejci
Journal:  Hum Mutat       Date:  2011-11-16       Impact factor: 4.878

2.  New functions for the Snail family of transcription factors: Two-faced proteins.

Authors:  Jesús Pérez-Losada; Isidro Sanchez-Garcia
Journal:  Cell Cycle       Date:  2010-07-15       Impact factor: 4.534

3.  Lysyl oxidase-like-2 (LOXL2) is a major isoform in chondrocytes and is critically required for differentiation.

Authors:  Mussadiq Iftikhar; Paola Hurtado; Manish V Bais; Nate Wigner; Danielle N Stephens; Louis C Gerstenfeld; Philip C Trackman
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

4.  Shaping embryos in Barcelona.

Authors:  Michel Labouesse; Lilianna Solnica-Krezel
Journal:  Nat Cell Biol       Date:  2009-01       Impact factor: 28.824

5.  A novel domain in histone deacetylase 1 and 2 mediates repression of cartilage-specific genes in human chondrocytes.

Authors:  Sohee Hong; Assia Derfoul; Lucilia Pereira-Mouries; David J Hall
Journal:  FASEB J       Date:  2009-06-26       Impact factor: 5.191

6.  FGF signaling in the osteoprogenitor lineage non-autonomously regulates postnatal chondrocyte proliferation and skeletal growth.

Authors:  Kannan Karuppaiah; Kai Yu; Joohyun Lim; Jianquan Chen; Craig Smith; Fanxin Long; David M Ornitz
Journal:  Development       Date:  2016-04-06       Impact factor: 6.868

Review 7.  A pathway to bone: signaling molecules and transcription factors involved in chondrocyte development and maturation.

Authors:  Elena Kozhemyakina; Andrew B Lassar; Elazar Zelzer
Journal:  Development       Date:  2015-03-01       Impact factor: 6.868

8.  Compensatory regulation of the Snai1 and Snai2 genes during chondrogenesis.

Authors:  Ying Chen; Thomas Gridley
Journal:  J Bone Miner Res       Date:  2013-06       Impact factor: 6.741

9.  Snail1 controls bone mass by regulating Runx2 and VDR expression during osteoblast differentiation.

Authors:  Cristina A de Frutos; Romain Dacquin; Sonia Vega; Pierre Jurdic; Irma Machuca-Gayet; M Angela Nieto
Journal:  EMBO J       Date:  2009-02-05       Impact factor: 11.598

10.  New insight on FGFR3-related chondrodysplasias molecular physiopathology revealed by human chondrocyte gene expression profiling.

Authors:  Laurent Schibler; Linda Gibbs; Catherine Benoist-Lasselin; Charles Decraene; Jelena Martinovic; Philippe Loget; Anne-Lise Delezoide; Marie Gonzales; Arnold Munnich; Jean-Philippe Jais; Laurence Legeai-Mallet
Journal:  PLoS One       Date:  2009-10-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.